Madrigal Pharmaceuticals
MDGL
MDGL
92 hedge funds and large institutions have $167M invested in Madrigal Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
22% less capital invested
Capital invested by funds: $213M → $167M (-$46.5M)
57% less call options, than puts
Call options by funds: $1.02M | Put options by funds: $2.35M
Holders
92
Holding in Top 10
1
Calls
$1.02M
Puts
$2.35M
Top Buyers
| 1 | +$2.71M | |
| 2 | +$1.21M | |
| 3 | +$1.14M | |
| 4 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
+$966K |
| 5 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$912K |
Top Sellers
| 1 | -$940K | |
| 2 | -$838K | |
| 3 | -$829K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$256K |
| 5 |
Barclays
London,
United Kingdom
|
-$133K |